Resistance patterns to anti-PD-1 therapy in metastatic melanoma

被引：3
|
作者：
Ozgun, Alpaslan
Sondak, Vernon K.
Markowitz, Joseph
机构：
[1] Univ S Florida, Morsani Coll Med, Moffitt Canc Ctr, Dept Cutaneous Oncol, Tampa, FL USA
[2] Univ S Florida, Morsani Coll Med, Dept Oncol Sci, Dept Cutaneous Oncol, Tampa, FL USA
来源：
CHINESE CLINICAL ONCOLOGY | 2016年 / 5卷 / 06期
关键词：
D O I：
10.21037/cco.2016.08.01
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [31] TNFα blockade overcomes resistance to anti-PD-1 in experimental melanoma
    Bertrand, Florie
    Montfort, Anne
    Marcheteau, Elie
    Imbert, Caroline
    Gilhodes, Julia
    Filleron, Thomas
    Rochaix, Philippe
    Andrieu-Abadie, Nathalie
    Levade, Thierry
    Meyer, Nicolas
    Colacios, Celine
    Segui, Bruno
    NATURE COMMUNICATIONS, 2017, 8
  • [32] Mechanisms of Resistance to Anti-PD-1 Immunotherapy in Melanoma and Strategies to Overcome It
    Zielinska, Magdalena K.
    Ciazynska, Magdalena
    Sulejczak, Dorota
    Rutkowski, Piotr
    Czarnecka, Anna M.
    BIOMOLECULES, 2025, 15 (02)
  • [33] TNFα blockade overcomes resistance to anti-PD-1 in experimental melanoma
    Florie Bertrand
    Anne Montfort
    Elie Marcheteau
    Caroline Imbert
    Julia Gilhodes
    Thomas Filleron
    Philippe Rochaix
    Nathalie Andrieu-Abadie
    Thierry Levade
    Nicolas Meyer
    Céline Colacios
    Bruno Ségui
    Nature Communications, 8
  • [34] Phase I Study of Androgen Deprivation Therapy in Combination with Anti-PD-1 in Melanoma Patients Pretreated with Anti-PD-1
    Robert, Caroline
    Lebbe, Celeste
    Lesimple, Thierry
    Lundstrom, Eija
    Nicolas, Valerie
    Gavillet, Bruno
    Crompton, Philippa
    Baroudjian, Barouyr
    Routier, Emilie
    Lejeune, Ferdy J.
    CLINICAL CANCER RESEARCH, 2023, 29 (05) : 858 - 865
  • [35] Modification of the Tumor Microenvironment Enhances Anti-PD-1 Immunotherapy in Metastatic Melanoma
    Shi, Guilan
    Scott, Megan
    Mangiamele, Cathryn G.
    Heller, Richard
    PHARMACEUTICS, 2022, 14 (11)
  • [36] Ipilimumab versus ipilimumab plus anti-PD-1 for metastatic melanoma reply
    da Silva, Ines Pires
    Ahmed, Tasnia
    Reijers, Irene L. M.
    Warner, Allison Betof
    Patrinely, James Randall
    Serra-Bellver, Patricio
    Allayous, Clara
    Mangana, Joanna
    Zimmer, Lisa
    Trojaniello, Claudia
    Klein, Oliver
    Gerard, Camille L.
    Michielin, Olivier
    Haydon, Andrew
    Ascierto, Paolo A.
    Carlino, Matteo S.
    Lebbe, Celeste
    Lorigan, Paul
    Johnson, Douglas B.
    Sandhu, Shahneen
    Lo, Serigne N.
    Menzies, Alexander M.
    Long, Georgina, V
    LANCET ONCOLOGY, 2021, 22 (08): : E343 - E344
  • [37] Safety and efficacy of anti-PD-1 antibodies in elderly patients with metastatic melanoma
    Rai, R.
    McQuade, J. L.
    Wang, D. Y.
    Park, J. J.
    Nahar, K.
    Sosman, J. A.
    Beckermann, K. E.
    Haydu, L. E.
    Lo, S.
    Rubinstein, S.
    Beckermann, K. E.
    McKean, M.
    Matthew, S.
    Guminski, A.
    Carlino, M. S.
    Davies, M.
    Johnson, D. B.
    Long, G. V.
    Menzies, A. M.
    ANNALS OF ONCOLOGY, 2016, 27
  • [38] The importance of anti-PD-1 dosing in the treatment of patients with inoperable or metastatic melanoma
    Cybulska-Stopa, B.
    Czarnecka, A. M.
    Ostaszewski, K.
    Zietek, M.
    Piejko, K.
    Dziura, R.
    Galus, L.
    Ziolkowska, B. E.
    Kieszko, S.
    Kempa-Kaminska, N.
    Calik, J.
    Seredynska, J.
    Rogala, P.
    Drosik-Kwasniewska, A.
    Kaminska-Winciorek, G.
    Kubiatowski, T.
    Suwinski, R.
    Mackiewicz, J.
    Rutkowski, P.
    ANNALS OF ONCOLOGY, 2021, 32 : S899 - S900
  • [39] The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients
    Matson, Vyara
    Fessler, Jessica
    Bao, Riyue
    Chongsuwat, Tara
    Zha, Yuanyuan
    Alegre, Maria-Luisa
    Luke, Jason J.
    Gajewski, Thomas F.
    SCIENCE, 2018, 359 (6371) : 104 - +
  • [40] Commensal microbiota associated with anti-PD-1 efficacy in metastatic melanoma patients
    Matson, Vyara
    Fessler, Jessica
    Bao, Riyue
    Chongsuwat, Tara
    Zha, Yuanyuan
    Alegre, Maria-Luisa
    Luke, Jason
    Gajewski, Thomas
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
12345